- RACE Act Increased the Number of Cancer Drugs with Required ...🔍
- The RACE Act and Pediatric Trials of Adult Cancer Drugs🔍
- RACE Act led to more required pediatric studies of cancer drugs🔍
- RACE Act increases number of cancer drugs investigated for use in ...🔍
- Pediatric Cancer Studies🔍
- Data Driven Insights🔍
- Fewer cancer drugs exempt from pediatric testing after RACE Act🔍
- RACE Act Increases Required Pediatric Studies for Cancer Drugs🔍
RACE Act Increased the Number of Cancer Drugs with Required ...
RACE Act Increased the Number of Cancer Drugs with Required ...
The RACE Act has resulted in increased requirements for more recently approved cancer drugs to be studied for potential use in pediatric patients.
The RACE Act and Pediatric Trials of Adult Cancer Drugs
In 2017, Congress passed the Research to Accelerate Cures and Equity (RACE) for Children Act to expand mandatory pediatric testing to cancer ...
RACE Act led to more required pediatric studies of cancer drugs
“To encourage study of therapeutics to treat pediatric cancers, many legislative efforts have been made, including the 2017 passage of the ...
RACE Act increases number of cancer drugs investigated for use in ...
The Research to Accelerate Cures and Equity (RACE) for Children Act has resulted in increased requirements for more recently approved cancer ...
The RACE Act and Pediatric Trials of Adult Cancer Drugs - PubMed
In 2017, Congress passed the Research to Accelerate Cures and Equity (RACE) for Children Act to expand mandatory pediatric testing to cancer ...
Pediatric Cancer Studies: Early Results of the Research to ...
It is too soon to know if the RACE Act will increase the number of drugs approved to treat pediatric cancers. This is because, according to ...
Data Driven Insights | Assessing the Impact of the Research to ...
In an effort to require further pediatric studies, the Research to Accelerate Cures and Equity (RACE) Act was signed into law in 2017, which ...
Fewer cancer drugs exempt from pediatric testing after RACE Act
Fewer cancer drugs were exempt from pediatric testing requirements after the Research to Accelerate Cures and Equity, or RACE, for Children ...
RACE Act Increases Required Pediatric Studies for Cancer Drugs
The RACE Act has increased the number of pediatric clinical trials that must be conducted for cancer therapies approved in adults.
RACE Act Poised to Advance Pediatric Cancer Research
On August 18, the Research to Accelerate Cures and Equity (RACE) for Children Act went into effect, potentially paving the way for more drug ...
FDA RACE for Children Act: What You Should Know | BioAgilytix
Short for Research to Accelerate Cures and Equity, the RACE Act went into effect on August 18, 2020, and significantly increased the number of required ...
Pediatric Trials for Cancer Therapies With Targets Potentially ...
The Research to Accelerate Cures and Equity (RACE) for Children Act was enacted in 2017 to authorize the US Food and Drug Administration (FDA) to require ...
New legislation to promote paediatric studies for new cancer ...
Among 106 adult cancer medicines approved before the RACE Act, none were required to be studied in paediatric settings. However, since the law's implementation, ...
Most recently, the Research to Accelerate Cures and Equity (RACE) for Children Act of 2017 gave the FDA authority to require the pharmaceutical ...
The RACE for Children Act Now in Full Effect
But these laws had a very modest impact on childhood cancer. In fact, exemptions carved out resulted in PREA having virtually no effect in ...
Medscape - More Drugs Tested in Pediatric Cancer: RACE for ...
The researchers found that prior to implementation of the RACE Act, none of the approved adult cancer therapeutics were required to be studied ...
The RACE for Children Act (Four Things You Need to Know)
On August 18, 2020, the RACE for Children Act went into effect and requires pharmaceutical companies to evaluate new drugs in children with ...
The Push to Increase Pediatric Research and Greater Diversity in ...
The RACE Act requires that drug developers—who intend to apply for FDA approval of certain adult cancer drugs—include in their plans an approach ...
A decade of FDA approvals for pediatric cancer indications
The RACE Act went into effect August 18, 2020, and while it has already been effective in increasing the number of post-marketing requirements (PMRs) for ...
Most cancer drugs must now be tested in paediatric cancers - Nature
To encourage the development of anticancer drugs for children, United States Congress approved the Research to Accelerate Cures and Equity (RACE) for Children ...